Table 3.

Prevalence of comorbidities in patients tested for SARS-CoV-2

Tested positive	Tested negative
Diabetes: n = 2 (40.00%)	Diabetes: n = 2 (2.67%)
Arterial hypertension: n = 3 (60.00%)	Arterial hypertension: n = 23 (30.67%)
Hypothyroidism: n = 0 (0%)	Hypothyroidism: n = 11 (14.67%)
Immunosuppression: n = 1 (20.00%)	Immunosuppression: n = 6 (8.00%)
Atrial fibrillation: n = 1 (20.00%)	Atrial fibrillation: n = 5 (6.67%)
Coronary artery disease: n = 0 (0%)	Coronary artery disease: n = 3 (4.00%)
Lung disease: n = 2 (40.00%)	Lung disease: n = 10 (13.33%)
Depression: n = 1 (20.00%)	Depression: n = 11 (14.67%)
Chronic kidney disease: n = 0 (0%)	Chronic kidney disease: n = 2 (2.67%)
RAAS inhibitors: n = 2 (40.00%)	RAAS inhibitors: n = 15 (20.00%)
Oral anticoagulation: n = 1 (20.00%)	Oral anticoagulation: n = 5 (6.67%)
Platelet inhibitors: n = 1 (20.00%)	Platelet inhibitors: n = 1 (1.33%)